During the past decade, Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico" are "Multiple Sclerosis" (4 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico" in a lesser frequency.

Most popular intervention types in "Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Antihistamine" (1 trials), "Fenebrutinib" (1 trials), "Methylprednisolone" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale S.Antonio Abate; Neurologia 2 - Sclerosi Multipla e Recupero Neurologico, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".